ÎÚÑ»´«Ã½

Jump to Main Content

Highlights of ASH®

Highlights of ASH in North America


About Highlights of ASH in North America

By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.

Throughout this meeting, you will be able to:

Blood icon

Access a program curated from highlights of the ASH annual meeting which covers the latest and most influential topics in hematology.

icon for engage interaction-an avatar looking at the screen

Engage in interactive panel discussions with speakers and attend small group lunch sessions with experts in the field.

An icon for a group of experts

Network with experts, exhibitors, and peers in a close-knit setting.

A calendar icon for scheduling events

Choose from several dates and locations to best meet your schedule.

View Program Information


Program Schedule

The program schedule below is identical for all 2025 Highlights of ASH in North America locations. The following information is preliminary and subject to change.

11:00 a.m. Registration and Exhibits Open (Lunch provided)
11:45 p.m. Welcome and Introductions
12:00 p.m. Inherited Disorders of Coagulation

Tyler Buckner, MD, MSc
University of Colorado

Seattle, WA 

Patrick Ellsworth, MD
University of North Carolina 
New York, NY
Chicago, IL 
Ayesha Zia, MD
University of Texas Southwestern 
Washington, DC
12:45 p.m. Transfusion Medicine
Grace Lee, MD
Duke University 
Chicago, IL 
Katerina Pavenski, MD, FRCPC
University of Toronto 
Seattle, WA
Washington, DC 
Michelle Zeller, MD
McMaster University 
New York, NY 
1:30 p.m. Sickle Cell Disease: Disease-Modifying and Curative Therapies

Maureen Okam Achebe, MD, MPH
Brigham and Women's Hospital 

New York, NY 
Cecelia Calhoun, MD, MPHS, MBA
Yale University

Seattle, WA
Chicago, IL 

Rakhi Naik, MD, MHS
Johns Hopkins University 
Washington, DC 
2:15 p.m. Panel Discussion
2:45 p.m. Coffee Break and Exhibits Open
3:00 p.m. Transplant

Miguel-Angel Perales, MD
Memorial Sloan Kettering Cancer Center 

New York, NY 

Bart L. Scott, MD
Fred Hutchinson Cancer Center

Seattle, WA
Washington, DC

Melody Smith, MD, MS
Stanford University
Chicago, IL
 
3:45 p.m.
Highlights in Aggressive Lymphoma

Paul Barr, MD
University of Rochester 

Chicago, IL 

Carla Casulo, MD
University of Rochester

Washington, DC 

Manali Kamdar, MD
University of Colorado

Seattle, WA 
Sarah Rutherford, MD
Weill Cornell Medicine 
New York, NY 
4:30 p.m. Highlights in Indolent Lymphoma and Chronic Lymphocytic Leukemia
Alexey Danilov, MD, PhD
City of Hope National Medical Center 
Seattle, WA 

Jia Ruan, MD, PhD
Weill Cornell Medicine 

New York, NY
Washington, DC

Deborah Stephens, DO
University of North Carolina
Chicago, IL 
5:15 p.m. Panel Discussion
5:45 p.m.  Highlights of ASH Day 1 Program Adjournment 
6:00 p.m. Satellite Symposia

7:00 a.m. Registration and Exhibits Open
(Breakfast provided)
7:45 a.m. Welcome, Introductions, and Announcements
8:00 a.m.

Intersection of Women’s Health and Hematology

Sarah H. O'Brien, MD, MSc
Nationwide Children's 

New York, NY
Washington, DC

Menaka Pai, MD FRCPC
McMaster University 
Chicago, IL 
Bethany Samuelson Bannow, MD
Oregon Health and Science University Medicine
Seattle, WA 
8:45 a.m.

Clinical Applications of Health Outcomes Research for Blood Cancers

Pamela Egan, MD
Maine Health 

Washington, DC 

Areej El-Jawahri, MD
Massachusetts General Hospital
Seattle, WA
Thomas W. LeBlanc, MD, MS, MA
Duke University 
New York, NY
Chicago, IL 
9:30 a.m.

Consultative Hematology

Cyrus Hsia, MD, FRCPC 
Western University 
New York, NY 
Jacquelyn M. Powers, MD 
Texas Children’s Hospital 
Chicago, IL 
Joseph Shatzel, MD 
Oregon Health and Science University Medicine 
Seattle, WA
Washington, DC 
10:15 a.m. Panel Discussion 
10:45 a.m. Coffee Break and Exhibits Open
11:00 a.m.

Myelodysplastic Syndromes and Clonal Hematopoiesis

Guillermo Garcia-Manero, MD
Anderson Cancer Center 

Chicago, IL

Morgan Jones, MD, PhD 
University of Michigan 
New York, NY
Washington, DC

Afaf Osman, MD 
University of Utah

Seattle, WA

11:45 a.m.

Myeloproliferative Neoplasms including Chronic Myeloid Leukemia

Chi-Joan How, MD
Brigham and Women’s Hospital 

Washington, DC 

Andrew Kuykendall, MD 
Moffitt Cancer Center
Seattle, WA 
Kristen Pettit, MD
University of Michigan

Chicago, IL 

Douglas Tremblay, MD 
Mount Sinai 

New York, NY 
12:30 p.m. Panel Discussion
1:00 p.m. Lunch with the Experts
(All Speakers and Attendees)
2:15 p.m.

Acute Lymphoblastic Leukemia

Patrick Burke, MD
University of Michigan

Seattle, WA 

Adam Duvall, MD 
University of Chicago 
Chicago, IL
Ryan Mattison, MD 
University of Wisconsin 
New York, NY
Washington, DC 
3:00 p.m.

Myeloma, MGUS, and Plasma Cell Disorders

Susan Bal, MD
University of Alabama at Birmingham

New York, NY

Doris Hansen, MD
Moffitt Cancer Center
Chicago, IL 

Jonathan Kaufman, MD
Emory University

Seattle, WA
Washington, DC

3:45 p.m.

Acute Myeloid Leukemia

Courtney DiNardo, MD 
MD Anderson Cancer Center 

Washington, DC

Charles Foucar, MD 
University of New Mexico

Chicago, IL 
Catherine Lai, MD, MPH 
University of Pennsylvania 

Seattle, WA 

Jerald Radich, MD
Fred Hutchinson Cancer Center 
New York, NY 
4:30 p.m. Panel Discussion
5:00 p.m. Closing Remarks and Adjournment

Acknowledgements

Thank you to our esteemed committee of experts dedicated to advancing the development of this meeting, and our company partners for providing educational grants in support of the 2025 Highlights of ASH in North America

  • Jia Ruan, MD, PhD, Chair, Weill Cornell Medicine 
  • Tyler Buckner, MD, MSc, University of Colorado Denver 
  • Pamela Egan, MD, Maine Health 
  • Manali Kamdar, MD, University of Colorado 
  • Jonathan L. Kaufman, MD, Emory University 
  • Rakhi Naik, MD, MHS, Johns Hopkins University 
  • Kristen Pettit, MD, University of Michigan 
  • Eric Tse, PhD, MBBS, Hong Kong University 
  • Michelle Zeller, MD, McMaster University